Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop’s classification
Frontiers in Physiology · 09.05.2023 · 14
DOI: 10.3389/fphys.2023.1130175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 09.05.2023. Verfasst von Agnes Bloch-Zupan und 25 weiteren Autor:innen. Beteiligte Einrichtung: Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amelogenesis imperfecta (AI) is a heterogeneous group of genetic rare diseases disrupting enamel development (Smith et al., Front Physiol, 2017a, 8, 333). The clinical enamel phenotypes can be described as hypoplastic, hypomineralized or hypomature and serve as a basis, together with the mode of inheritance, to Witkop’s classification (Witkop, J Oral Pathol, 1988, 17, 547–553). AI can be described in isolation or associated with others symptoms in syndromes. Its occurrence was estimated to range from 1/700 to 1/14,000. More than 70 genes have currently been identified as causative.
Objectives
We analyzed using next-generation sequencing (NGS) a heterogeneous cohort of AI patients in order to determine the molecular etiology of AI and to improve diagnosis and disease management.
Methods
Individuals presenting with so called “isolated” or syndromic AI were enrolled and examined at the Reference Centre for Rare Oral and Dental Diseases (O-Rares) using D4/phenodent protocol ( www.phenodent.org ). Families gave written informed consents for both phenotyping and molecular analysis and diagnosis using a dedicated NGS panel named GenoDENT. This panel explores currently simultaneously 567 genes. The study is registered under NCT01746121 and NCT02397824 ( https://clinicaltrials.gov/ ).
Results
GenoDENT obtained a 60% diagnostic rate. We reported genetics results for 221 persons divided between 115 AI index cases and their 106 associated relatives from a total of 111 families. From this index cohort, 73% were diagnosed with non-syndromic amelogenesis imperfecta and 27% with syndromic amelogenesis imperfecta. Each individual was classified according to the AI phenotype. Type I hypoplastic AI represented 61 individuals (53%), Type II hypomature AI affected 31 individuals (27%), Type III hypomineralized AI was diagnosed in 18 individuals (16%) and Type IV hypoplastic-hypomature AI with taurodontism concerned 5 individuals (4%). We validated the genetic diagnosis, with class 4 (likely pathogenic) or class 5 (pathogenic) variants, for 81% of the cohort, and identified candidate variants (variant of uncertain significance or VUS) for 19% of index cases. Among the 151 sequenced variants, 47 are newly reported and classified as class 4 or 5. The most frequently discovered genotypes were associated with MMP20 and FAM83H for isolated AI. FAM20A and LTBP3 genes were the most frequent genes identified for syndromic AI. Patients negative to the panel were resolved with exome sequencing elucidating for example the gene involved ie ACP4 or digenic inheritance.
Conclusion
NGS GenoDENT panel is a validated and cost-efficient technique offering new perspectives to understand underlying molecular mechanisms of AI. Discovering variants in genes involved in syndromic AI ( CNNM4, WDR72, FAM20A … ) transformed patient overall care. Unravelling the genetic basis of AI sheds light on Witkop’s AI classification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France.
- Université de Strasbourg, Institut d'études avancées (USIAS), Strasbourg, France.
- Hôpitaux Universitaires de Strasbourg (HUS), Pôle de Médecine et Chirurgie Bucco-dentaires, Hôpital Civil, Centre de référence des maladies rares orales et dentaires, O-Rares, Filiére Santé Maladies rares TETE COU, Euro…
- Université de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), IN-SERM U1258, CNRS- UMR7104, Illkirch, France.
- Eastman Dental Institute, University College London, London, United Kingdom.
- Hôpitaux Universitaires de Strasbourg, Laboratoires de diagnostic génétique, Institut de Génétique Médicale d'Alsace, Strasbourg, France.
Zitieren
APA
Bloch-Zupan, A., Rey, T., Jimenez-Armijo, A., Kawczynski, M., Kharouf, N., O-Rare consortium, Dure-Molla, M., Noirrit, E., Hernandez, M., Joseph-Beaudin, C., Lopez, S., Tardieu, C., Thivichon-Prince, B., ERN Cranio Consortium, Dostalova, T., Macek, M., International Consortium, Alloussi, M. E., Qebibo, L., …, & Laugel-Haushalter, V. (2023). Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop’s classification. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1130175
Vancouver
Bloch-Zupan A, Rey T, Jimenez-Armijo A, Kawczynski M, Kharouf N, O-Rare consortium, et al. Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop’s classification. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1130175
BibTeX
@article{BlochZupan2023,
author = {Bloch-Zupan, Agnes and Rey, Tristan and Jimenez-Armijo, Alexandra and Kawczynski, Marzena and Kharouf, Naji and O-Rare consortium, O-Rare consortium and Dure-Molla, Muriel de La and Noirrit, Emmanuelle and Hernandez, Magali and Joseph-Beaudin, Clara and Lopez, Serena and Tardieu, Corinne and Thivichon-Prince, Béatrice and ERN Cranio Consortium, ERN Cranio Consortium and Dostalova, Tatjana and Macek, Milan and International Consortium, International Consortium and Alloussi, Mustapha El and Qebibo, Leila and Morkmued, Supawich and Pungchanchaikul, Patimaporn and Orellana, Blanca Urzúa and Manière, Marie-Cécile and Gérard, Bénédicte and Bugueno, Isaac Maximiliano and Laugel-Haushalter, Virginie},
title = {Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop’s classification},
journal = {Frontiers in Physiology},
year = {2023},
volume = {14},
doi = {10.3389/fphys.2023.1130175}
}
EUVIMED